Skip to main content
Top
Published in: Abdominal Radiology 5/2012

01-10-2012

Peritoneal carcinomatosis: comparison of dynamic contrast-enhanced magnetic resonance imaging with surgical and histopathologic findings

Authors: Bernhard Daniel Klumpp, Philip Aschoff, Nina Schwenzer, Michael Fenchel, Ingmar Koenigsrainer, Claudius Falch, Bjoern Bruecher, Claus D. Claussen, Alfred Koenigsrainer, Christina Pfannenberg, Ulrich Kramer, Stephan Miller

Published in: Abdominal Radiology | Issue 5/2012

Login to get access

Abstract

Objective

In patients with peritoneal carcinomatosis (PC) accurate preoperative assessment is essential to determine indication and surgical procedure to ensure optimal outcome. Purpose of our study was to assess the diagnostic accuracy (DA) of multiphasic dynamic contrast-enhanced MRI to determine the extent of PC in correlation with surgical and histopathological findings.

Materials and methods

14 Patients with proven PC were examined on a 1.5T system before peritonectomy and hyperthermic intraperitoneal chemotherapy. Patient preparation included oral application of 2000 mL mannitol solution and 40 mg butylscopolaminiumbromid i.v. Coronal contrast-enhanced multiphasic dynamic T1w 3D gre sequences (T1W DCE) (0.15 mmol Gd-chelate/kg bw) covering the whole abdomen were acquired (TR 2.9 ms, TE 1.1 ms, resolution 2.0 × 2.0 × 1.8 mm, FOV 400 × 400 mm). MRI was assessed by two radiologists and correlated with surgical exploration (SE) and histopathology for each segment based on the peritoneal cancer index proposed by Sugarbaker et al.

Results

In total, 182 segments were evaluated. PC was found in 118/121 of 182 segments (reader 1/2) by MRI and in 131 segments by SE. In 4/7 segments MRI was false positive. False negative segments 17/17 in MRI did not result in irresectability. The positive predictive value for PC per segment of MRI was 97%/94%, the negative predictive value 73%/72%, the sensitivity 87%/87% and the specificity 92%/86%. The DA was 88%/87%.

Conclusion

T1W DCE is an accurate and clinical valuable tool for the preoperative assessment of peritoneal tumor spread.
Literature
1.
go back to reference Brown G, Kirkham A, Williams GT, et al. (2004) High-resolution MRI of the anatomy important in total mesorectal excision of the rectum. AJR Am J Roentgenol 182:431–439CrossRefPubMed Brown G, Kirkham A, Williams GT, et al. (2004) High-resolution MRI of the anatomy important in total mesorectal excision of the rectum. AJR Am J Roentgenol 182:431–439CrossRefPubMed
2.
go back to reference Cotton F, Pellet O, Gilly FN, et al. (2006) MRI evaluation of bulky tumor masses in the mesentery and bladder involvement in peritoneal carcinomatosis. Eur J Surg Oncol 32:1212–1216CrossRefPubMed Cotton F, Pellet O, Gilly FN, et al. (2006) MRI evaluation of bulky tumor masses in the mesentery and bladder involvement in peritoneal carcinomatosis. Eur J Surg Oncol 32:1212–1216CrossRefPubMed
3.
go back to reference Glehen O, Mohamed F, Gilly FN (2004) Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol 5:219–228CrossRefPubMed Glehen O, Mohamed F, Gilly FN (2004) Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol 5:219–228CrossRefPubMed
4.
go back to reference Yan TD, Sim J, Morris DL (2007) Selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and perioperative intraperitoneal chemotherapy. Ann Surg Oncol 14:1807–1817CrossRefPubMed Yan TD, Sim J, Morris DL (2007) Selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and perioperative intraperitoneal chemotherapy. Ann Surg Oncol 14:1807–1817CrossRefPubMed
5.
go back to reference Quayyum A, Coakley FV, Westphalen AC, et al. (2005) Role of CT and MRI in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. Gynecol Oncol 96:301–306CrossRef Quayyum A, Coakley FV, Westphalen AC, et al. (2005) Role of CT and MRI in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. Gynecol Oncol 96:301–306CrossRef
6.
go back to reference Forstner R (2007) Radiological staging of ovarian cancer: imaging findings and contribution of CT and MRI. Eur Radiol 17:3223–3246CrossRefPubMed Forstner R (2007) Radiological staging of ovarian cancer: imaging findings and contribution of CT and MRI. Eur Radiol 17:3223–3246CrossRefPubMed
7.
go back to reference Tempany CM, Zou KH, Silverman SG, et al. (2000) Staging of advanced ovarian cancer: comparison of imaging modalities-report from the Radiology Oncology Group. Radiology 215:761–767CrossRefPubMed Tempany CM, Zou KH, Silverman SG, et al. (2000) Staging of advanced ovarian cancer: comparison of imaging modalities-report from the Radiology Oncology Group. Radiology 215:761–767CrossRefPubMed
8.
go back to reference Coakley FV, Choi PH, Gougoutas CA, et al. (2002) Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology 223:495–499CrossRefPubMed Coakley FV, Choi PH, Gougoutas CA, et al. (2002) Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology 223:495–499CrossRefPubMed
9.
go back to reference Javitt MC, Fleischer AC, Andreotti RF (2005) Staging and follow-up of ovarian cancer. Reston: American college of Radiology recommendations Javitt MC, Fleischer AC, Andreotti RF (2005) Staging and follow-up of ovarian cancer. Reston: American college of Radiology recommendations
10.
go back to reference Low RN, Sigeti JS (1994) MR imaging of peritoneal disease: comparison of contrast enhanced fast multiplanar spoiled gradient recalled and spin echo imaging. AJR Am J Roentgenol 163:1131–1140CrossRefPubMed Low RN, Sigeti JS (1994) MR imaging of peritoneal disease: comparison of contrast enhanced fast multiplanar spoiled gradient recalled and spin echo imaging. AJR Am J Roentgenol 163:1131–1140CrossRefPubMed
11.
go back to reference Semelka RC, Lawrence PH, Shoenut JP, et al. (1993) Primary ovarian cancer: prospective comparison of contrast enhanced CT and pre- and postcontrast, fat-suppressed MR imaging, with histopathologic correlation. J Magn Reson Imaging 3:99–106CrossRefPubMed Semelka RC, Lawrence PH, Shoenut JP, et al. (1993) Primary ovarian cancer: prospective comparison of contrast enhanced CT and pre- and postcontrast, fat-suppressed MR imaging, with histopathologic correlation. J Magn Reson Imaging 3:99–106CrossRefPubMed
12.
go back to reference Low RN, Saleh F, Song SY, et al. (1999) Treated ovarian cancer: comparison of MR imaging with serum CA-125 level and physical examination—a longitudinal study. Radiology 211:519–528CrossRefPubMed Low RN, Saleh F, Song SY, et al. (1999) Treated ovarian cancer: comparison of MR imaging with serum CA-125 level and physical examination—a longitudinal study. Radiology 211:519–528CrossRefPubMed
13.
go back to reference Low RN, Duggan B, Barone RM, et al. (2005) Treated ovarian cancer: MR imaging, laparotomy reassessment, and serum CA-125 values compared with clinical outcome at 1 year. Radiology 235:918–926CrossRefPubMed Low RN, Duggan B, Barone RM, et al. (2005) Treated ovarian cancer: MR imaging, laparotomy reassessment, and serum CA-125 values compared with clinical outcome at 1 year. Radiology 235:918–926CrossRefPubMed
14.
go back to reference Forstner R, Hricak H, Powell CB, et al. (1995) Ovarian cancer recurrence: value of MR imaging. Radiology 196:715–720CrossRefPubMed Forstner R, Hricak H, Powell CB, et al. (1995) Ovarian cancer recurrence: value of MR imaging. Radiology 196:715–720CrossRefPubMed
15.
go back to reference Low RN, Carter WD, Saleh F, et al. (1995) Ovarian cancer: comparison of findings with perfluorocarbon-enhanced MR imaging, In-111-CYT-103 immunoscintigraphy, and CT. Radiology 195:391–400CrossRefPubMed Low RN, Carter WD, Saleh F, et al. (1995) Ovarian cancer: comparison of findings with perfluorocarbon-enhanced MR imaging, In-111-CYT-103 immunoscintigraphy, and CT. Radiology 195:391–400CrossRefPubMed
16.
go back to reference Low RN, Barone RM, Lacey C, et al. (1997) Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium containing contrast agents compared with unenhanced MR imaging and CT. Radiology 204:513–520CrossRefPubMed Low RN, Barone RM, Lacey C, et al. (1997) Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium containing contrast agents compared with unenhanced MR imaging and CT. Radiology 204:513–520CrossRefPubMed
17.
go back to reference Miller FH, Rini NJ, Keppke AL (2006) MRI of adenocarcinoma of the pancreas. AJR Am J Roentgenol 187:365–374CrossRef Miller FH, Rini NJ, Keppke AL (2006) MRI of adenocarcinoma of the pancreas. AJR Am J Roentgenol 187:365–374CrossRef
18.
go back to reference Furukawa T, Ueda J, Takahashi S, et al. (1999) Peritoneal serous papillary carcinoma: radiological appearance. Abdom Imaging 24:78–81CrossRefPubMed Furukawa T, Ueda J, Takahashi S, et al. (1999) Peritoneal serous papillary carcinoma: radiological appearance. Abdom Imaging 24:78–81CrossRefPubMed
19.
go back to reference Stafford-Johmson DB, Bree RL, Francis IR, Korobkin M (1998) CT appearance of primary serous carcinoma of the peritoneum. AJR Am J Roentgenol 171:687–689CrossRef Stafford-Johmson DB, Bree RL, Francis IR, Korobkin M (1998) CT appearance of primary serous carcinoma of the peritoneum. AJR Am J Roentgenol 171:687–689CrossRef
20.
go back to reference Chopra S, Laurie LR, Chintapalli KN, Valente PT, Dodd GD 3rd (2000) Primary papillary serous carcinoma of the peritoneum: CT-pathologic correlation. J Comput Assist Tomogr 24:395–399CrossRefPubMed Chopra S, Laurie LR, Chintapalli KN, Valente PT, Dodd GD 3rd (2000) Primary papillary serous carcinoma of the peritoneum: CT-pathologic correlation. J Comput Assist Tomogr 24:395–399CrossRefPubMed
21.
go back to reference Zissin R, Hertz M, Shapiro-Feinberg M, et al. (2001) Primary serous papillary carcinoma of the peritoneum: CT findings. Clin Radiol 56:740–745CrossRefPubMed Zissin R, Hertz M, Shapiro-Feinberg M, et al. (2001) Primary serous papillary carcinoma of the peritoneum: CT findings. Clin Radiol 56:740–745CrossRefPubMed
22.
go back to reference Hideo M, Aoki J, Taketomi A, Sato N, Endo K (2004) Serous surface papillary carcinoma of the peritoneum: clinical, radiologic and pathologic findings in 11 patients. AJR Am J Roentgenol 183:923–928CrossRef Hideo M, Aoki J, Taketomi A, Sato N, Endo K (2004) Serous surface papillary carcinoma of the peritoneum: clinical, radiologic and pathologic findings in 11 patients. AJR Am J Roentgenol 183:923–928CrossRef
23.
go back to reference Jaquet P, Jelinek JS, Steves MA, Sugarbaker PH (1993) Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer 72:1631–1636CrossRef Jaquet P, Jelinek JS, Steves MA, Sugarbaker PH (1993) Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer 72:1631–1636CrossRef
24.
go back to reference Buy JN, Malbec L, Ghossain MA, Guinet C, Ecoiffier J (1989) Magnetic resonance imaging of pseudomyxoma peritonei. Eur J Radiol 9:115–118PubMed Buy JN, Malbec L, Ghossain MA, Guinet C, Ecoiffier J (1989) Magnetic resonance imaging of pseudomyxoma peritonei. Eur J Radiol 9:115–118PubMed
25.
go back to reference Hamrick-Turner JE, Chiechi MV, Abbit PL, Ros PR (1992) Neoplastic and inflammatory processes of the peritoneum, omentum and mesentery: diagnosis with CT. Radiographics 12:1051–1068CrossRefPubMed Hamrick-Turner JE, Chiechi MV, Abbit PL, Ros PR (1992) Neoplastic and inflammatory processes of the peritoneum, omentum and mesentery: diagnosis with CT. Radiographics 12:1051–1068CrossRefPubMed
26.
go back to reference Bechtold RE, Chen MYM, Loggie BW, Jackson SL, Geisinger K (2001) CT appearance of disseminated peritoneal adenomucinosis. Abdom Imaging 26:406–410CrossRefPubMed Bechtold RE, Chen MYM, Loggie BW, Jackson SL, Geisinger K (2001) CT appearance of disseminated peritoneal adenomucinosis. Abdom Imaging 26:406–410CrossRefPubMed
27.
go back to reference Jacquet P, Jelinek JS, Chang D, Koslowe P, Sugarbaker PH (1995) Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery. J Am Coll Surg 181:530–538PubMed Jacquet P, Jelinek JS, Chang D, Koslowe P, Sugarbaker PH (1995) Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery. J Am Coll Surg 181:530–538PubMed
28.
go back to reference Low RN, Semelka RC, Worawattanakul S, Alzate GD, Sigeti JS (1999) Extrahepatic abdominal imaging in patients with malignancy: comparison of MR imaging and helical CT with subsequent surgical correlation. Radiology 210:625–632CrossRefPubMed Low RN, Semelka RC, Worawattanakul S, Alzate GD, Sigeti JS (1999) Extrahepatic abdominal imaging in patients with malignancy: comparison of MR imaging and helical CT with subsequent surgical correlation. Radiology 210:625–632CrossRefPubMed
29.
go back to reference Hussain SM, Outwater EK, Siegelman ES (2000) MR imaging features of pelvic mucinous carcinomas. Eur Radiol 19:885–891CrossRef Hussain SM, Outwater EK, Siegelman ES (2000) MR imaging features of pelvic mucinous carcinomas. Eur Radiol 19:885–891CrossRef
30.
go back to reference Low RN, Barone RM, Gurney LM, Muller WD (2008) Mucinous appendical neoplasms: preoperative MR staging and classification compared with surgical and histopathologic findings. AJR Am J Roentgenol 190:656–665CrossRefPubMed Low RN, Barone RM, Gurney LM, Muller WD (2008) Mucinous appendical neoplasms: preoperative MR staging and classification compared with surgical and histopathologic findings. AJR Am J Roentgenol 190:656–665CrossRefPubMed
31.
go back to reference Funicelli L, Travaini LL, Landoni F, et al. (2010) Peritoneal carcinomatosis from ovarian cander: the role of CT and [18F]FDG-PET/CT. Abdom Imaging 35:701–707CrossRefPubMed Funicelli L, Travaini LL, Landoni F, et al. (2010) Peritoneal carcinomatosis from ovarian cander: the role of CT and [18F]FDG-PET/CT. Abdom Imaging 35:701–707CrossRefPubMed
32.
go back to reference Priest AN, Gill AB, Kataoka M, et al. (2010) Dynamic contrast-enhanced MRI in ovarian cancer: initial experience at 3 tesla in primary and metastatic disease. Magn Reson Med 63:1044–1049CrossRefPubMed Priest AN, Gill AB, Kataoka M, et al. (2010) Dynamic contrast-enhanced MRI in ovarian cancer: initial experience at 3 tesla in primary and metastatic disease. Magn Reson Med 63:1044–1049CrossRefPubMed
33.
go back to reference Marin D, Catalano C, Baski M, et al. (2010) 64-Section multi-detector row CT in the preoperative diagnosis of peritoneal carcinomatosis: correlation with histopathological findings. Abdom Imaging 35:694–700CrossRefPubMed Marin D, Catalano C, Baski M, et al. (2010) 64-Section multi-detector row CT in the preoperative diagnosis of peritoneal carcinomatosis: correlation with histopathological findings. Abdom Imaging 35:694–700CrossRefPubMed
34.
go back to reference Sato Y, Ichikawa T, Motosugi U, et al. (2011) Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET/CT, diffusion-weighted MRI and contrast-enhanced MDCT. AJR Am J Roentgenol 196:447–453CrossRef Sato Y, Ichikawa T, Motosugi U, et al. (2011) Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET/CT, diffusion-weighted MRI and contrast-enhanced MDCT. AJR Am J Roentgenol 196:447–453CrossRef
35.
go back to reference Iafrate F, Ciolina M, Sammartino P et al. (2011) Peritoneal carcinomatosis: imaging with 64-MDCT and 3T MRI with diffusion-weighted imaging. Abdom Imaging (epub ahead of print). Iafrate F, Ciolina M, Sammartino P et al. (2011) Peritoneal carcinomatosis: imaging with 64-MDCT and 3T MRI with diffusion-weighted imaging. Abdom Imaging (epub ahead of print).
36.
go back to reference Dromain C, Leboulleux S, Auperin A, et al. (2008) Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT. Abdom Imaging 33:87–93CrossRefPubMed Dromain C, Leboulleux S, Auperin A, et al. (2008) Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT. Abdom Imaging 33:87–93CrossRefPubMed
Metadata
Title
Peritoneal carcinomatosis: comparison of dynamic contrast-enhanced magnetic resonance imaging with surgical and histopathologic findings
Authors
Bernhard Daniel Klumpp
Philip Aschoff
Nina Schwenzer
Michael Fenchel
Ingmar Koenigsrainer
Claudius Falch
Bjoern Bruecher
Claus D. Claussen
Alfred Koenigsrainer
Christina Pfannenberg
Ulrich Kramer
Stephan Miller
Publication date
01-10-2012
Publisher
Springer US
Published in
Abdominal Radiology / Issue 5/2012
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-011-9825-7

Other articles of this Issue 5/2012

Abdominal Radiology 5/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.